New Technologies for Analysis of Extracellular Vesicles

被引:1354
作者
Shao, Huilin [1 ,2 ,3 ,4 ]
Im, Hyungsoon [5 ,6 ]
Castro, Cesar M. [5 ,7 ]
Breakefield, Xandra [6 ,8 ]
Weissleder, Ralph [5 ,6 ,9 ]
Lee, Hakho [5 ,6 ]
机构
[1] Natl Univ Singapore, Dept Biomed Engn, Singapore 117583, Singapore
[2] Natl Univ Singapore, Dept Surg, Singapore 117583, Singapore
[3] Natl Univ Singapore, Biomed Inst Global Hlth Res & Technol, Singapore 117599, Singapore
[4] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore
[5] Massachusetts Gen Hosp, Ctr Syst Biol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[7] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[8] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[9] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA
基金
新加坡国家研究基金会;
关键词
TUMOR-DERIVED MICROVESICLES; MESENCHYMAL STEM-CELL; MULTIVESICULAR BODY BIOGENESIS; FLOW-CYTOMETRIC ANALYSIS; LONG NONCODING RNA; PROTEOMIC ANALYSIS; PANCREATIC-CANCER; MEMBRANE-VESICLES; PROTEIN AGGREGATION; EXOSOME ISOLATION;
D O I
10.1021/acs.chemrev.7b00534
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Extracellular vesicles (EVs) are diverse, nanoscale membrane vesicles actively released by cells. Similar-sized vesicles can be further classified (e.g., exosomes, microvesicles) based on their biogenesis, size, and biophysical properties. Although initially thought to be cellular debris, and thus under-appreciated, EVs are now increasingly recognized as important vehicles of intercellular communication and circulating biomarkers for disease diagnoses and prognosis. Despite their clinical potential, the lack of sensitive preparatory and analytical technologies for EVs poses a barrier to clinical translation. New analytical platforms including molecular ones are thus actively being developed to address these challenges. Recent advances in the field are expected to have far-reaching impact in both basic and translational studies. This article aims to present a comprehensive and critical overview of emerging analytical technologies for EV detection and their clinical applications.
引用
收藏
页码:1917 / 1950
页数:34
相关论文
共 292 条
[1]   On-Chip Immunoelectrophoresis of Extracellular Vesicles Released from Human Breast Cancer Cells [J].
Akagi, Takanori ;
Kato, Kei ;
Kobayashi, Masashi ;
Kosaka, Nobuyoshi ;
Ochiya, Takahiro ;
Ichiki, Takanori .
PLOS ONE, 2015, 10 (04)
[2]   Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF) [J].
Akers, Johnny C. ;
Ramakrishnan, Valya ;
Nolan, John P. ;
Duggan, Erika ;
Fu, Chia-Chun ;
Hochberg, Fred H. ;
Chen, Clark C. ;
Carter, Bob S. .
PLOS ONE, 2016, 11 (02)
[3]   Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies [J].
Akers, Johnny C. ;
Gonda, David ;
Kim, Ryan ;
Carter, Bob S. ;
Chen, Clark C. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (01) :1-11
[4]   A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles [J].
Akyurekli, Celine ;
Le, Yevgeniya ;
Richardson, Richard B. ;
Fergusson, Dean ;
Tay, Jason ;
Allan, David S. .
STEM CELL REVIEWS AND REPORTS, 2015, 11 (01) :150-160
[5]   Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR [J].
Al-Nedawi, Khalid ;
Meehan, Brian ;
Kerbel, Robert S. ;
Allison, Anthony C. ;
Rak, Janusz .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :3794-3799
[6]   High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients [J].
Allenson, K. ;
Castillo, J. ;
San Lucas, F. A. ;
Scelo, G. ;
Kim, D. U. ;
Bernard, V. ;
Davis, G. ;
Kumar, T. ;
Katz, M. ;
Overman, M. J. ;
Foretova, L. ;
Fabianova, E. ;
Holcatova, I. ;
Janout, V. ;
Meric-Bernstam, F. ;
Gascoyne, P. ;
Wistuba, I. ;
Varadhachary, G. ;
Brennan, P. ;
Hanash, S. ;
Li, D. ;
Maitra, A. ;
Alvarez, H. .
ANNALS OF ONCOLOGY, 2017, 28 (04) :741-747
[7]   Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers [J].
Alvarez, M. Lucrecia ;
Khosroheidari, Mahdieh ;
Ravi, Rupesh Kanchi ;
DiStefano, Johanna K. .
KIDNEY INTERNATIONAL, 2012, 82 (09) :1024-1032
[8]   Malignant effusions and immunogenic tumour-derived exosomes [J].
Andre, F ;
Schartz, NEC ;
Movassagh, M ;
Flament, C ;
Pautier, P ;
Morice, P ;
Pomel, C ;
Lhomme, C ;
Escudier, B ;
Le Chevalier, T ;
Tursz, T ;
Amigorena, S ;
Raposo, G ;
Angevin, E ;
Zitvogel, L .
LANCET, 2002, 360 (9329) :295-305
[9]   Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression [J].
Andreu, Zoraida ;
Otta Oshiro, Renan ;
Redruello, Alberto ;
Lopez-Martin, Soraya ;
Gutierrez-Vazquez, Cristina ;
Morato, Esperanza ;
Isabel Marina, Ana ;
Olivier Gomez, Carlos ;
Yanez-Mo, Maria .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 98 :70-79
[10]   Tetraspanins in extracellular vesicle formation and function [J].
Andreu, Zoraida ;
Yanez-Mo, Maria .
FRONTIERS IN IMMUNOLOGY, 2014, 5